BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12680749)

  • 1. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England.
    Biswas PN; Wilton LV; Shakir SA
    J Psychopharmacol; 2003 Mar; 17(1):121-6. PubMed ID: 12680749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 3. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England.
    Biswasl PN; Wilton LV; Pearcel GL; Freemantle S; Shakir SA
    J Psychopharmacol; 2001 Dec; 15(4):265-71. PubMed ID: 11769820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Biswas PN; Wilton LV; Shakir SW
    J Hum Hypertens; 2002 Nov; 16(11):795-803. PubMed ID: 12444541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 10. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
    Stimmel GL; Dopheide JA; Stahl SM
    Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of mirtazapine-induced delirium in organic brain disorder.
    Bailer U; Fischer P; Küfferle B; Stastny J; Kasper S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):239-43. PubMed ID: 10954066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 13. Disability and borderline personality symptoms.
    Sansone RA; Hruschka J; Vasudevan A; Miller SN
    Psychosomatics; 2003; 44(5):442. PubMed ID: 12954928
    [No Abstract]   [Full Text] [Related]  

  • 14. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
    Felthous AR; Wenger PJ; Hoevet R
    Pharmacotherapy; 2010 Apr; 30(4):145e-50e. PubMed ID: 20334466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
    Haddjeri N; Blier P; de Montigny C
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():11-7. PubMed ID: 8930005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 18. New onset multimodal hallucinations associated with mirtazapine: a case report.
    Padala KP; Padala PR; Malloy T; Burke WJ
    Int Psychogeriatr; 2010 Aug; 22(5):837-9. PubMed ID: 20500925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Pisa syndrome after administration of a single dose of mirtazapine.
    Méndez Guerrero A; Llamas S; Murcia FJ; Ruíz J
    Clin Neuropharmacol; 2013; 36(4):133-4. PubMed ID: 23783006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gynecomastia by mirtazapin].
    Navarro-González M; Alberdi-Leniz A; Gené-Badia J
    Med Clin (Barc); 2006 Jun; 127(1):37-8. PubMed ID: 16796941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.